The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis

Published:2016-04-09 Issue:24 Volume:7 Page:37277-37287
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Wei¹,Zhou Jian-Guo²,Sun Yi¹,Zhang Lei¹,Xing Bao-Cai¹

Affiliation:

1. Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, PR China

2. Department of Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi Medical University, Zunyi, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting response to neoadjuvant chemotherapy for colorectal liver metastasis using deep learning on prechemotherapy cross‐sectional imaging;Journal of Surgical Oncology;2024-05-07

2. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases;HPB;2024-05

3. Renin–Angiotensin Inhibitor, Captopril, Attenuates Growth of Patient-Derived Colorectal Liver Metastasis Organoids;International Journal of Molecular Sciences;2024-03-14

4. Preoperative chemotherapy in upfront resectable colorectal liver metastases: New elements for an old dilemma?;Cancer Treatment Reviews;2024-03

5. Neoadjuvant chemotherapy versus upfront surgery for resectable colorectal liver metastases: A systemic review and meta‐analysis;Surgical Practice;2023-11-02